Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yilin Li, Yang Wang, Na Zhang, Shenzhi Zhou, Ying Peng & Jiang Zheng. (2021) Glutathione conjugation and protein modification resulting from metabolic activation of venlafaxine in vitro and in vivo. Xenobiotica 51:11, pages 1303-1317.
Read now
Read now
Tjerk Bueters, Sanja Juric, Anna-Karin Sohlenius-Sternbeck, Yin Hu & Johan Bylund. (2013) Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human. Xenobiotica 43:7, pages 607-616.
Read now
Read now
ALEJANDRO HERNÁANDEZ, LUIS CONSTANDIL, CLAUDIO LAURIDO, TERESA PELISSIER, FABIEN MARCHAND, DENIS ARDID, ABDELKRIM ALLOUI, ALAIN ESCHALIER & RUBÉN SOTO-MOYANO. (2004) VENLAFAXINE-INDUCED DEPRESSION OF WIND-UP ACTIVITY IN MONONEUROPATHIC RATS IS POTENTIATED BY INHIBITION OF BRAIN 5-HT1A RECEPTOR EXPRESSION IN VIVO. International Journal of Neuroscience 114:2, pages 229-242.
Read now
Read now
Articles from other publishers (33)
Natalie N. Maffeo, Cary M. Springer & Julia D. Albright. (2023) A retrospective study on the clinical use and owner perception of venlafaxine efficacy as part of a multimodal treatment for canine fear, anxiety, and aggression. Journal of Veterinary Behavior 64-65, pages 54-59.
Crossref
Crossref
Abdul Aala Fazli, Bala Krishna Panigrahy, Varinder Kumar, Syed Naiem Raza, Bilal Ahmad Zarger, Taha Umair Wani, Shavej Ahmad, Arshad Khuroo & Nisar Ahmad Khan. (2022) Multiple-reaction monitoring (MRM) LC–MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits. Scientific Reports 12:1.
Crossref
Crossref
Delphine Metz, Tiphaine Medam & Sylvia Masson. (2021) Double-blind, placebo-controlled trial of venlafaxine to treat behavioural disorders in cats: a pilot study. Journal of Feline Medicine and Surgery 24:6, pages 539-549.
Crossref
Crossref
Karen L. Overall. 2019. Pharmacotherapeutics for Veterinary Dispensing. Pharmacotherapeutics for Veterinary Dispensing
377
401
.
Karol A. Mathews, Melissa Sinclair, Andrea M. Steele & Tamara GrubbKarol Mathews. 2018. Analgesia and Anesthesia for the Ill or Injured Dog and Cat. Analgesia and Anesthesia for the Ill or Injured Dog and Cat
17
50
.
Karol A. Mathews, Melissa Sinclair, Andrea M. Steele & Tamara GrubbKarol Mathews & Tamara Grubb. 2018. Analgesia and Anesthesia for the Ill or Injured Dog and Cat. Analgesia and Anesthesia for the Ill or Injured Dog and Cat
144
164
.
Guodong Gu, Michelle Black, Colt Cookson, Anna Fiorella, Yinghe Li, Steven H. Gorman & Ray Bakhtiar. (2018) Validation of an LC-MS/MS method for simultaneous quantification of venlafaxine and its five metabolites in rat plasma and its application in a pharmacokinetic study. Journal of Chromatography B 1087-1088, pages 29-35.
Crossref
Crossref
Mark E. Epstein. 2018. Canine Sports Medicine and Rehabilitation. Canine Sports Medicine and Rehabilitation
479
501
.
Rui Xue, Ying Li, Xin-Hua He, Zeng-Liang Jin, Shi-Yong Fan, Ting-Ting Zhang, Nuo-Min Li, Li Yuan, Ai-Ping Zheng, Bo-Hua Zhong, Yun-Feng Li & You-Zhi Zhang. (2016) Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors. Journal of Psychopharmacology 31:3, pages 377-386.
Crossref
Crossref
Diego Castanares-Zapatero, Nathalie Gillard, Arnaud Capron, Vincent Haufroid & Philippe Hantson. (2016) Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism. Forensic Science International 266, pages e48-e51.
Crossref
Crossref
Qiong‐Yin Fan, Rui Xue, Ying Li, Ting‐Ting Zhang, Xin‐Hua He, Shi‐Yong Fan, Yun‐Feng Li, Bo‐Hua Zhong, You‐Zhi Zhang & Jin Li. (2016)
Antidepressant‐like Effects of
ZBH
2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor
. CNS Neuroscience & Therapeutics 22:8, pages 700-706.
Crossref
Crossref
José I. Serrano-Contreras, Isabel García-Pérez, María E. Meléndez-Camargo & Luis G. Zepeda-Vallejo. (2016) NMR-based metabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment. Journal of Pharmaceutical and Biomedical Analysis 123, pages 82-92.
Crossref
Crossref
Mark E. Epstein. (2014) Adjunctive, Pain-Modifying, Analgesic Drugs. Topics in Companion Animal Medicine 29:2, pages 30-34.
Crossref
Crossref
Butch KuKanich. (2013) Outpatient Oral Analgesics in Dogs and Cats Beyond Nonsteroidal Antiinflammatory Drugs. Veterinary Clinics of North America: Small Animal Practice 43:5, pages 1109-1125.
Crossref
Crossref
园园 朱. (2013) Synthesis of Venlafaxine Hydrochloride. Studies in Synthetic Chemistry 01:01, pages 1-3.
Crossref
Crossref
Loren M. Berry, Chao Li & Zhiyang Zhao. (2011)
Species Differences in Distribution and Prediction of Human
V
ss
from Preclinical Data
. Drug Metabolism and Disposition 39:11, pages 2103-2116.
Crossref
Crossref
Kosalaram Goteti, C.Edwin Garner & Iftekhar Mahmood. (2010) Prediction of Human Drug Clearance from Two Species: A Comparison of Several Allometric Methods. Journal of Pharmaceutical Sciences 99:3, pages 1601-1613.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. Journal of Pharmacy and Pharmacology 55:7, pages 939-949.
Crossref
Crossref
Luis Delucchi, Pedro Martino, Alicia Baldovino, Paula Pessina & Álvaro Rodrigues. (2010) Use of venlafaxine in the treatment of a canine narcolepsy-cataplexy case. Journal of Small Animal Practice 51:2, pages 132-132.
Crossref
Crossref
Iftekhar Mahmood. (2009) Role of Fixed Coefficients and Exponents in the Prediction of Human Drug Clearance: How Accurate are the Predictions from One or Two Species?. Journal of Pharmaceutical Sciences 98:7, pages 2472-2493.
Crossref
Crossref
N.R. Mirza, E.Ø. Nielsen & K.B. Troelsen. (2007) Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:4, pages 858-866.
Crossref
Crossref
K. B. Troelsen, E. Ø. Nielsen & N. R. Mirza. (2005) Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Psychopharmacology 181:4, pages 741-750.
Crossref
Crossref
Fabien Marchand, Teresa Pelissier, Alain Eschalier, Denis Ardid, Abdelkrim Alloui, Rubén Soto-Moyano, Mauricio Mondaca, Claudio Laurido, Luis Constandil & Alejandro Hernández. (2004) Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats. Brain Research 1008:2, pages 288-292.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Crossref
Iftekhar Mahmood, Martin David Green & J. Edward Fisher. (2003) Selection of the First-Time Dose in Humans: Comparison of Different Approaches Based on Interspecies Scaling of Clearance. The Journal of Clinical Pharmacology 43:7, pages 692-697.
Crossref
Crossref
Fabien Marchand, Abdelkrim Alloui, Eric Chapuy, Didier Jourdan, Teresa Pelissier, Denis Ardid, Alejandro Hernandez & Alain Eschalier. (2003) Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. Pain 103:3, pages 229-235.
Crossref
Crossref
Fabien Marchand, Abdelkrim Alloui, Eric Chapuy, Alejandro Hernandez, Teresa Pelissier, Denis Ardid & Alain Eschalier. (2003) The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system. Neuroscience Letters 342:1-2, pages 105-108.
Crossref
Crossref
Julie G Hensler. (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sciences 72:15, pages 1665-1682.
Crossref
Crossref
Iftekhar Mahmood. (2002) Interspecies Scaling: Predicting Oral Clearance in Humans. American Journal of Therapeutics 9:1, pages 35-42.
Crossref
Crossref
A Frazer & S Benmansour. (2002) Delayed pharmacological effects of antidepressants. Molecular Psychiatry 7:S1, pages S23-S28.
Crossref
Crossref
I. Mahmood. (2001) Interspecies Scaling: Is a priori Knowledge of Cytochrome P450 Isozymes Involved in Drug Metabolism Helpful in Prediction of Clearance in Humans from Animal Data?. Drug Metabolism and Drug Interactions 18:2.
Crossref
Crossref
Gustav Apelqvist, Cecilia Wikell, Björn Carlsson, Stephan Hjorth, Peter B.F. Bergqvist, Johan Ahlner & Finn Bengtsson. (2000) Dynamic and Kinetic Effects of Chronic Citalopram Treatment in Experimental Hepatic Encephalopathy. Clinical Neuropharmacology 23:6, pages 304-317.
Crossref
Crossref
Jean‐Claude Béïque, Claude de Montigny, Pierre Blier & Guy Debonnel. (2009) Blockade of 5‐Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. British Journal of Pharmacology 125:3, pages 526-532.
Crossref
Crossref